Information Provided By: 
Fly News Breaks for April 11, 2018
EW
Apr 11, 2018 | 07:41 EDT
SunTrust analyst Bruce Nudell raised his price target on Edwards Lifesciences to $180, saying the company stands to benefit from its competitive edge as the Structural Heart market reaches $13B by 2030. Nudell expects Edwards Lifesciences to retain just over 50% market share while forecasting higher annual incidence of qualified for intervention aortic stenosis patients among the fast-growing elderly population. The analyst keeps his Buy rating on Edwards Lifesciences.
News For EW From the Last 2 Days
There are no results for your query EW
